BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26205622)

  • 1. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
    Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
    Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
    Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
    Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H
    Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.
    Agirre X; Novo FJ; Calasanz MJ; Larráyoz MJ; Lahortiga I; Valgañón M; García-Delgado M; Vizmanos JL
    Mol Carcinog; 2003 Dec; 38(4):201-8. PubMed ID: 14639659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
    Messina M; Chiaretti S; Fedullo AL; Piciocchi A; Puzzolo MC; Lauretti A; Gianfelici V; Apicella V; Fazi P; Te Kronnie G; Testi AM; Vitale A; Guarini A; Foà R
    Br J Haematol; 2017 Aug; 178(4):583-587. PubMed ID: 28439887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia.
    Tesio M; Trinquand A; Ballerini P; Hypolite G; Lhermitte L; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Asnafi V
    Leukemia; 2017 Dec; 31(12):2594-2600. PubMed ID: 28539671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
    Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
    Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.
    Schiffman JD; Wang Y; McPherson LA; Welch K; Zhang N; Davis R; Lacayo NJ; Dahl GV; Faham M; Ford JM; Ji HP
    Cancer Genet Cytogenet; 2009 Aug; 193(1):9-18. PubMed ID: 19602459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
    Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
    Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
    Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
    Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
    Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
    Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
    J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.
    Sulong S; Moorman AV; Irving JA; Strefford JC; Konn ZJ; Case MC; Minto L; Barber KE; Parker H; Wright SL; Stewart AR; Bailey S; Bown NP; Hall AG; Harrison CJ
    Blood; 2009 Jan; 113(1):100-7. PubMed ID: 18838613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
    Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
    Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
    Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
    Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
    Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
    Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperdiploidy with trisomy 9 and deletion of the CDKN2A locus in T-cell acute lymphoblastic leukemia.
    Healey K; Gray SL; Halligan GE; McKenzie AS; de Chadarévian JP; Morrissette JJ
    Cancer Genet Cytogenet; 2009 Apr; 190(2):121-4. PubMed ID: 19380031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.